Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rosseti Volga reported for 6 months of 2024 by RAS

7/26/24 MRKV

Mordovenergosbyt reported for 6 months of 2024 by RAS

7/26/24 MRSB

Yuzhuralzoloto has completed construction of a factory at Vysokoye

7/26/24 UGLD

Samolet reported for 6 months of 2024 by RAS

7/26/24 SMLT

Rosseti North-West reported for 6 months of 2024 by RAS

7/26/24 MRKZ

Government authorities are slowing down YouTube

7/25/24 VKCO

TMK reported for 6 months by RAS

7/25/24 TRMK

QIFA tests settlements in digital currencies

7/25/24 QIFA

Bank Saint-Petersburg will buy back up to 20 million shares

7/25/24 BSPB

Finam to launch two pre-IPO funds

7/25/24 OTCI